Peter Ciszewski has worked in health care publishing and media for most of his career, from overseeing editorial and production departments to running companies. He has founded publications, web platforms, and companies focused on clinical and health care issues.
For most of his career, Peter has been focused on rare diseases and oncology. He started working with Genzyme on programs focused on lysosomal storage diseases soon after the company received approval for Cerezyme, one of the first life-saving and blockbuster medications for rare disease patients. He has since worked across hundreds of rare diseases, creating content and promotional and educational programs.
Most recently, Peter founded and manages CheckRare, providing news, insight, and clinical perspective to physicians, patients, and the rare disease community.
